TLRY Tilray Brands, Inc.
Healthcare$5.45+3.02%ClosedMarket Cap: $651.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.39
P/S
0.55
EV/EBITDA
-0.41
DCF Value
$-48.40
FCF Yield
-14.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
27.7%
Operating Margin
-172.3%
Net Margin
-156.2%
ROE
-92.8%
ROA
-89.0%
ROIC
-100.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $282.2M | 26.6% | $-27.1M | $-36.3M | $— | — |
| Q2 null | $303.9M | 26.4% | $-31.1M | $-62.8M | $— | — |
| Q1 null | $287.8M | 27.4% | $2.9M | $-442.3K | $— | — |
| Q4 null | $308.1M | 30.1% | $-1.98B | $-1.75B | $— | — |
| FY null | $1.13B | 29.3% | $-3.13B | $-3.00B | $— | — |
| Q3 null | $268.3M | 28.0% | $-1.10B | $-1.14B | $— | — |
| Q2 null | $295.1M | 29.0% | $-59.1M | $-119.4M | $— | — |
| Q1 null | $269.8M | 29.8% | $-49.3M | $-52.8M | $— | — |
| Q4 null | $313.2M | 35.8% | $-22.5M | $-43.3M | $— | — |
| FY null | $1.07B | 28.3% | $-238.1M | $-333.8M | $— | — |
| Q3 2024 | $255.6M | 26.2% | $-111.4M | $-125.8M | $-1.63 | — |
| Q2 2024 | $262.4M | 24.5% | $-56.5M | $-66.4M | $-0.95 | — |